What's new

Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 5, Status: Authorised

May 19, 2025 - 14:55
 0
Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Flixabi, infliximab, D...

Next Article

European Medicines Agency’s Data Protection Notice for the Organisation Manageme...

Related Posts

Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Date of authorisation: 12/12/2007, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0